Bingyu Li
Capital Medical University(CN)Peking University(CN)Beijing Jishuitan Hospital(CN)Zhujiang Hospital(CN)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Immune Cell Function and Interaction, Immune cells in cancer, Immunotherapy and Immune Responses, Phagocytosis and Immune Regulation
Most-Cited Works
- → Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019(2021)220 cited
- → Non-steroidal mineralocorticoid receptor antagonist finerenone ameliorates mitochondrial dysfunction via PI3K/Akt/eNOS signaling pathway in diabetic tubulopathy(2023)89 cited
- → An orally available PD-1/PD-L1 blocking peptide OPBP-1-loaded trimethyl chitosan hydrogel for cancer immunotherapy(2021)84 cited
- → cGAS-STING pathway aggravates early cerebral ischemia-reperfusion injury in mice by activating NCOA4-mediated ferritinophagy(2022)72 cited
- → Cancer immunotherapy based on blocking immune suppression mediated by an immune modulator LAIR-1(2020)68 cited
- → Diosgenin Attenuates Lipopolysaccharide-Induced Parkinson’s Disease by Inhibiting the TLR/NF-κB Pathway(2018)57 cited